Billets de Michelle Dawson

Billet publié sur Twitter/X le 03/10/2023 11:17

Twitter/X Essai clinique clinicaltrials.gov Extrait cité dans le billet Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

1 réponse intégrée de Michelle Dawson

03/10/2023 11:23

Note: included autistics must have "proof of a professional diagnosis of autism OR meet or exceed clinical cut-off on the Social Responsiveness Scale (SRS-2) autism screening instrument"?
Note: one of the 10 secondary outcomes is "Potential Negative Effects of Intervention"

Voir la réponse sur Twitter/X

Liens cités structurés

1 ressource citée

Essai clinique Récupéré Publication clinicaltrials.gov

University of North Carolina, Chapel Hill, University of Virginia, Augusta University, Patient-Centered Outcomes Research Institute (2024). Comparing Cognitive-Behavioral Therapy Versus Mindfulness-Based Therapy for Autistic Adults. ClinicalTrials.gov. University of North Carolina, Chapel Hill.

Date de publication
17/01/2024
Identifiant
NCT06060860
Auteurs
University of North Carolina, Chapel Hill, University of Virginia, Augusta University, Patient-Centered Outcomes Research Institute
Source
ClinicalTrials.gov
Type de référence
clinical_trial
Éditeur
University of North Carolina, Chapel Hill
Source de métadonnées
clinicaltrials.gov

Résumé

Autistic adults are at a greater risk for mental health problems compared to the general population, with 50% meeting criteria for a co-occurring psychiatric condition. Depression and anxiety are the most common of these conditions among autistic adults, contributing to long-term detrimental effects on health, day-to-day functioning, and quality of life. This study will conduct the first large-scale head-to-head comparison of the two most widely studied mental health interventions for autistic adults: cognitive-behavioral therapy (CBT) and mindfulness-based therapy (MBT). Both interventions are well-established, empirically supported treatments for depression and anxiety in the general population, and both interventions have demonstrated efficacy among autistic adults. However, their comparative effectiveness and heterogeneity of treatment effects have not been established in autistic adults. Both interventions will be delivered by telehealth.